baber/WOPTO huggingface dataset:
Patent NZ-569764-A (NZ)
Title: Method for improved breast milk feeding to reduce the risk of allergy
Inventor: BJORKSTEN BENGT
IPC: A61K45/00
Filed: 2005-05-30
Abstract: Disclosed is a stabilized bacterial composition comprising cells of a freeze-dried viable lactic acid bacterial strain in an edible vegetable oil wherein the oil is prepared by a vacuum drying step. Also disclosed is the use of a pharmaceutical composition comprising dried cultures of viable Lactobacillus and a vacuum dried edible vegetable oil for the manufacture of a medicament for prevention of allergy in feeding babies; and a method for increasing the survival of dried culture of a lactic acid bacterial strain comprising preparing a stabilized bacterial composition of a freeze-dried viable lactic acid bacterial strain in an edible vegetable oil, wherein the oil is prepared by a vacuum drying step. (62) Divided Out of 550527
Patent NZ-571287-A (NZ)
Title: A bracket and a crossbar assembly for a roof rack
Inventor: HUBBARD PETER DOUGLAS
IPC: B60R9/04
Filed: 2008-09-15
Abstract: A roof rack crossbar bracket includes a crossbar housing 121 for receiving and engaging the end of a cross bar and opposed first and second jaws for engaging the rack rail. The first jaw 107 is a fixed jaw on the crossbar housing and the second jaw 102 pivots on an axis at the second end 104 of the body 103 of the jaw so that the first end 105 is urged toward the first jaw to clamp the rail. The moving and urging mechanism is a nut 111 winding on a captive screw 108.
Patent NZ-582102-A (NZ)
Title: Linear expression constructs for production of influenza virus particles
Inventor: KITTEL CHRISTIAN
IPC: A61K39/00
Filed: 2008-06-26
Abstract: Disclosed is a linear expression construct free of any conventional amplification and/or selection sequences comprising an RNA polymerase I (poll) promoter and a poll termination signal, inserted between a RNA polymerase Il (polll) promoter and a polyadenylation signal useful for the expression of segments of viral RNA, preferably influenza viruses. The inventive construct is useful for efficient and fast production of viral particles, especially for producing vaccine formulations for the treatment of epidemic and/or pandemic diseases.
Patent NZ-586962-A (NZ)
Title: Abuse resistant melt extruded formulation having reduced alcohol interaction
Inventor: ROTH WOLFGANG
IPC: A61K31/277
Filed: 2009-01-26
Abstract: Disclosed is a melt-extruded abuse-resistant drug delivery composition for delivering a drug that has potential for dose dumping in alcohol (i.e., reduced drug-alcohol interaction), comprising: (a) A drug having potential for dose dumping in alcohol selected from a group consisting of verapamil, gammahydroxybutyrate, and flunitrazepam; and (b) A matrix having a polymer, copolymer or combinations thereof, wherein a monomer is natrium-alignate. Further disclosed is the use of said composition in preparing a medicament.
Patent NZ-587754-A (NZ)
Title: TNF alpha antibody for hiradenitis suppurativa
Inventor: BANERJEE SUBHASHIS
IPC: C07K16/24
Filed: 2003-07-18
Abstract: Provided is the use of an isolated human anti-TNFa antibody, or an antigen binding portion thereof, in the preparation of a medicament for treating Hidradenitis suppurativa (HS) in a subject, wherein the antibody is an isolated human antibody, or an antigen binding portion thereof, that dissociates from human TNFa with a Kd of 1 x 10-8 M or less and a Koff rate constant of 1 x 10-3 s-1 or less, both determined by surface plasmon resonance, and neutralizes human INFa cytotoxicity in a standard in vitro L929 assay with an IC50 of 1 x 10-7 M or less.
Patent NZ-594779-A (NZ)
Title: Stealth wireless communications facility
Inventor: OVERTON ANDREW
IPC: B63B15/00
Filed: 2010-02-17
Abstract: 594779 A system for mounting equipment for wireless transmission and reception comprises a hull (102) having the appearance of a sailboat hull and configured for dry dock storage. The system further includes a mast (104) attached to the hull, one or more antennas (103) for wireless transmission and reception attached to the top of the mast. Further, one or more compartments (106) lie within the hull, configured for mounting transmission and reception equipment, and one or more weatherproof access doors provide access to the compartments. At least one of the one or more access doors is disposed at a bottom of a side surface of the hull at least partially below a water line of the hull to give access to the compartments from the outside of the hull.
Patent NZ-595157-A (NZ)
Title: Inhaler
Inventor: WRIGHT MATTHEW PAUL
IPC: A61M15/00
Filed: 2010-01-25
Abstract: 595157 An inhalation device (1) comprising a base having a slot for insertion of a single blister containing a dose of medicament to be inhaled into the base is disclosed. The inhaler has a mouthpiece (2) pivotally mounted to the base which carries a blister piercing element (14, 15) operable to pierce a blister received in the slot when the mouthpiece is pivoted relative to the base. When a user inhales on the mouthpiece, the dose is entrained in an airflow and flows out of the blister through the mouthpiece and into the user’s airway.
Patent NZ-599930-A (NZ)
Title: Pharmaceutical compositions for the stimulation of stem cells.
Inventor: GORDON-BERESFORD ROLAND
IPC: A61K38/30
Filed: 2010-12-02
Abstract: 599930 Disclosed is a human or veterinary pharmaceutical composition (B) for the stimulation of stem cells, including at least five stem cells-stimulating-agents selected from the group consisting of TGFβ-1, BMP-4, FGF-2, IGF-1, Activin-A, Cardiotrophin 1, Cardiogenol C and mixtures thereof, and at least one pharmaceutically acceptable excipient, wherein the composition does not include alpha-thrombin. Further disclosed is the therapeutic use of said composition for treating heart diseases.
Patent NZ-601751-A (NZ)
Title: Flotation machine
Inventor: PELTOLA ALEKSI
IPC: B01F33/45
Filed: 2011-02-22
Abstract: 601751 Disclosed is a flotation machine including a flotation cell (1), which comprises a vertical side wall (2) and a bottom (3). An air distribution and mixing device (4) is arranged in the vicinity of the bottom for distributing air to the slurry for forming froth and mixing the slurry in the flotation cell. The air distribution and mixing device includes a rotor part (5) that comprises air distribution apertures (6). A drive shaft (7) extends vertically in the flotation cell. The rotor part (5) is attached to the lower end of the drive shaft (7). The drive shaft comprises a hollow interior (8), which constitutes a flow channel for conducting flotation air to the air distribution holes (6) of the rotor part. An electric motor (9) is arranged to rotate the drive shaft (7). The electric motor is supported by a separate supporting framework (10), which is on top of the flotation cell. The electric motor (9) is a permanent magnet motor that comprises a vertical rotor axis (11), the lower end of which is in permanent contact directly with the upper end of the drive shaft (7).
Patent NZ-603179-A (NZ)
Title: Prostaglandin e2 binding proteins and uses thereof
Inventor: GU JIJIE
IPC: A61K39/395
Filed: 2009-07-08
Abstract: Disclosed is a binding protein capable of binding prostaglandin E2 (PGE2), wherein the binding protein comprises an antigen binding domain containing variable heavy (VH) and variable light (VL) domains comprising framework and complementarity determining region (CDR) sequences, wherein said CDR sequences comprise: GYTFTKYWLG (SEQ ID NO: 54), DIYPGYDYTHYNEKFKD (SEQ ID NO: 55), SDGSSTY (SEQ ID NO: 56), TSSQNIVHSNGNTYLE (SEQ ID NO: 57), KVSNRFSG (SEQ ID NO: 58), and FQVSHVPYT (SEQ ID NO: 59).
Patent NZ-607430-A (NZ)
Title: Composition and method to suppress whey flavor
Inventor: DIERBACH LISA A
IPC: A23C21/08
Filed: 2013-02-22
Abstract: Disclosed herein is a whey containing composition comprising whey and an amount of thaumatin effective to mask flavour notes imparted to the composition from whey. In one embodiment the composition is a food product comprising about 0% to about 32% fat, whey, and about 0.01 ppm to about 1 ppm thaumatin, and wherein the whey and the thaumatin are present in a ration from about 1,2000,000:1 to about 4000:1.
Patent NZ-607600-A (NZ)
Title: Compositions for the treatment of diseases
Inventor: BAR-OR DAVID
IPC: B65D69/00
Filed: 2011-09-07
Abstract: The disclosure relates to a method of inhibiting vascular hyperpermeability in an animal in need thereof. The method comprises administering an effective amount of a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification. The disclosure also relates to a method of modulating the cytoskeleton of an endothelial cell in an animal. The method comprises administering an effective amount of a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification. The disclosure further relates to a kit. The kit comprises a diketopiperazme, a prodrug of a diketopiperazme or a pharmaceutically-acceptable salt of either of them to the animal, wherein the diketopiperazme has the formula set forth in the specification.
Patent NZ-611530-A (NZ)
Title: Multilayer heat-shrinkable film and containers made therefrom
Inventor: PALEARI MARIO
IPC: B65D75/00
Filed: 2011-12-05
Abstract: The disclosure relates to a multilayer heat-shrinkable film comprising: a) an outer heat sealable layer b) at least one layer comprising a blend of from 80 – 50 percent by weight of ethylene homopolymer and/or ethylene-alfa olefin copolymers and from 50 – 20 percent by weight of ethylene vinyl acetate copolymer, c) at least one internal gas-barrier layer, and d) at least one layer comprising a material selected from the group consisting of acrylate-based resin and acrylic acid-based resin, and blends thereof with ethylene homopolymer and/or ethylene/alpha-olefin (E/AO) copolymer and/or adhesive materials, in which the acrylic/acrylate resin is from 80 to 20 percent by weight. The disclose also relates to flexible packaging containers made therefrom comprising a self-sealing film.
Patent NZ-614229-A (NZ)
Title: Dry matter meter measurement detection method and apparatus
Inventor: LYNCH GRAHAM BRUCE
IPC: G01N27/22
Filed: 2012-06-01
Abstract: Disclosed is a dry matter capacitance meter suitable for determining the dry matter content of forage. The meter has a capacitance probe for determining a capacitance value indicative of the dry matter content of at least a representative sample of the forage. A motion sensor contacts the ground and detects the occurrence of a sampling action completed by the meter, and a data storage element records capacitance probe measurement values indicative of dry matter content of forage. A processor reads recorded capacitance probe measurements from the data storage element and calculates the dry matter content of the forage.
Patent NZ-615915-A (NZ)
Title: Compositions and methods for treating, diagnosing and monitoring disease
Inventor: MORGAN RICHARD
IPC: G01N33/50
Filed: 2012-03-28
Abstract: Disclosed is the use of a therapeutically effective amount of a composition which inhibits the expression of the TMEM92 gene or which inhibits the function of the TMEM92 protein, in the manufacture of a medicament for the treatment of cancer. Also disclosed is a method for diagnosing cancer in a patient or for identifying a patient at risk of developing cancer, the method comprising: (a) determining an amount of a biomarker in a sample obtained from a patient, the biomarker comprising:- (i) a nucleic acid sequence comprising SEQ ID NO:1, or a functional fragment/variant that has at least about 70% nucleic acid sequence identity with SEQ ID NO:1, or a nucleic acid molecule which comprises said nucleic acid sequence; or (ii) an amino acid sequence comprising SEQ ID NO:2, or a functional fragment/variant that has at least about 70% amino acid sequence identity with SEQ ID NO:2, or an amino acid molecule which comprises said amino acid sequence, optionally wherein the biomarker is a cancer biomarker selected from a prostate cancer biomarker, a non-small cell lung cancer biomarker and breast cancer biomarker.
Patent NZ-618262-A (NZ)
Title: Novel maytansinoid derivatives with peptide linker and conjugates thereof
Inventor: WIDDISON WAYNE C
IPC: A61P35/00
Filed: 2012-06-21
Abstract: Disclosed is a cell-binding agent-cytotoxic agent conjugate represented by the following structural formula as disclosed in the abstract drawing, wherein the different embodiments of the conjugate are as disclosed in the specification. Further disclosed is the use of said conjugate in the manufacture of a medicament for the treatment of cancer.
Patent NZ-629897-A (NZ)
Title: A seat support assembly
Inventor: PAUL DOUGLAS
IPC: B63B29/04
Filed: 2014-02-05
Abstract: A seat support assembly including a substantially tubular containing jacket (23) having a first end with an inwardly oriented return lip (28) and a second end closable with a sealing closure (20), a guide portion (24) adapted to be at least partially received by a seat stand, a resilient separator (22) abutting a portion of the guide portion and the sealing closure, an adapter to attach to the guide portion and at least abut an inner surface (29, 30) of the containing jacket wherein the assembly damps oscillation between the adapter and the containing jacket.
Patent NZ-631090-A (NZ)
Title: A fully dry central tube type air blown micro optical cable
Inventor: RUAN YUNFANG
IPC: G02B6/44
Filed: 2013-04-25
Abstract: Disclosed is an all-dry central tube air blown micro optical cable. The optical cable comprises an outer sheath (5) and a loose tube (2) disposed within the outer sheath (5). The loose tube (2) is adapted to receive one or more optical fibers (1). The water-blocking yarns are (3) included inside the loose tube (2) and wherein an outer surface of the outer sheath (5) includes circumferentially spaced longitudinally extending grooves.
Patent NZ-705404-A (NZ)
Title: System for optimising an enclosed space
Inventor: MUNN DEREK
IPC: F24F13/10
Filed: 2013-09-09
Abstract: A system for optimising one or more environmental parameters of an enclosed space comprising first and second relatively enclosed regions, such as a living space and a roof space within a building, is disclosed. The system comprises an internal sensor, in the first region, and an external sensor, external to the enclosed space, for measuring respective environmental parameters. The system also comprises a controller and a diverter valve. The controller is configured to specify the first region’s ideal internal environmental parameter, and compare this specified parameter with the measured first region’s internal parameter and the measured external parameter to determine whether the diverter valve directs air from the first or second enclosed region to exhaust through the ventilator.
Patent NZ-708877-A (NZ)
Title: Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid or a derivative thereof and flufenacet
Inventor: BECKER JOERG
IPC: A01N43/40
Filed: 2013-12-18
Abstract: Provided herein are herbicidal compositions and methods utilizing a combination of herbicidally active ingredients, the combination comprising: (a) a compound of the formula (I) or an agriculturally acceptable salt or a C1-4 alkyl or benzyl ester of thereof and (b) flufenacet, wherein the weight ratio of (a) to (b) is about 1.25 - 10 of (a) to about 30 - 240 of (b), with the proviso that the combination does not include glufosinate, L-glufosinate, bialaphos, or diflufenican.
Patent NZ-711079-A (NZ)
Title: Method for determining the state of a refractory lining of a metallurgical vessel for molten metal in particular
Inventor: LAMMER GREGOR
IPC: F27D21/00
Filed: 2014-03-07
Abstract: The invention relates to a method for determining the state of a fire-resistant lining of a vessel (10) containing molten metal in particular. In the process, maintenance data, production data, and wall thicknesses at least at locations with the highest degree of wear are measured or ascertained together with additional process parameters of a vessel (10) after the vessel (10) has been used. Said data is then collected and stored in a data structure. A calculating model is generated from at least some of the measured or ascertained data or parameters, and said data or parameters are evaluated by means of the calculating model using calculations and subsequent analyses. Thus, related or integral ascertaining processes and subsequent analyses can be carried out, on the basis of which optimizations relating to both the vessel lining as well as the complete process of the molten metal in the vessel are achieved.
Patent NZ-716190-A (NZ)
Title: Valved male luer connector
Inventor: GUALA GIANNI
IPC: A61M39/26
Filed: 2016-01-20
Abstract: The present invention regards an improvement of known valved male luer connectors, in particular for providing easier and safer connection of the connector to medical fluid lines. This is achieved due to the inlet portion of the tubular member being rotatable with respect to the casing. The present invention provides a valved male luer connector comprising a casing, a tubular member having an inlet portion configured for connection to a medical line and an outlet portion with a terminal open end, and an elastic hollow element secured to the casing and enclosing the tubular member. The elastic hollow element has a terminal wall normally sealingly closing the terminal end of the outlet portion of the tubular member and has a cut. The connector also comprises a collar interposed between the casing and the elastic hollow element. The collar is axially displaceable, following thrust engagement by a female connector connectable to the male connector, to cause a stretching deformation of the elastic hollow element and a consequent opening of a flow passage between the inlet portion and the outlet portion of the tubular member. The connector also comprises a flange connected to the casing. The tubular member comprises a groove receiving a radially extending projection of the flange to allow the inlet portion to rotate with respect to the casing. The projection comprises an outer side closest to the open end and an inner side on an opposite end of the projection relative to the outer side, where the outer side has a larger radial dimension than the inner side. The tubular member as a whole is freely rotatable with respect to the casing in opposite directions of rotation and the flange comprises a hollow appendage through which the tubular member is rotatably engaged following an axial snap-fit coupling thereof. The tubular member being rotatable with respect to the casing enables it be connected to a female connector in an easier fashion, due to the fact that any twisting of the medical line is efficiently avoided, but also more safely since it avoids the risk of inadvertent detachment of the medical line due to a torsion thereof.
Patent NZ-719784-A (NZ)
Title: Specific anti-cd38 antibodies for treating human cancers
Inventor: DESLANDES ANTOINE
IPC: C07K16/28
Filed: 2014-10-31
Abstract: The present disclosure concerns an antibody that specifically binds CD38 which is capable of killing a CD38+ cell by induction of apoptosis, antibody-dependent cell- mediated cytotoxicity (ADCC), and complement-dependent cytotoxicity. The disclosed antibody may be used as a medicament or in the making of a medicament, wherein the antibody is to be administered to a human subject in a safe therapeutic dose of about 20 mg/kg or below. In one embodiment, the medicament is for treating CD38+ multiple Myeloma in humans. In particular, the present invention relates to the use of the anti-CD38 antibody, hu38SB19/SAR650984, for treating patients having relapsed or refractory multiple myeloma wherein the multiple myeloma is relapsed or refractory from previous treatment with lenalidomide or bortezomib. The hu38SB19/SAR650984 antibody is to be administered at 10mg/kg or 20mg/kg once every two weeks.
Patent NZ-754173-A (NZ)
Title: Pharmaceutical composition of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
Inventor: Yang Chuan-Ching
IPC: A61K31/18
Filed: 2017-12-18
Abstract: Provided is a use of a pharmaceutical composition including a benzenesulfonamide derivative, i.e. para-toluene sulfonamide, and pharmaceutically acceptable carriers in the manufacture of medicaments for treating adenoid cystic carcinoma.
Patent NZ-754407-A (NZ)
Title: Il2 and tnf mutant immunoconjugates
Inventor: NERI DARIO
IPC: C07K19/00
Filed: 2017-11-08
Abstract: The present application relates to a fusion protein comprising interleukin 2 (IL2), and a mutant of tumour necrosis factor, such as tumour necrosis factor alpha (TNFα), and an antibody molecule. The antibody molecule preferably binds to an antigen associated with neoplastic growth and/or angiogenesis, such as the Extra-Domain A (EDA) or Extra-Domain B (EDB) of fibronectin. The fusion protein may be used in the treatment of cancer.
Patent NZ-763641-A (NZ)
Title: Electronic aerosol provision device
Inventor: WRIGHT JEREMY
IPC: A24F40/70
Filed: 2018-10-19
Abstract: An e cigarette comprising a housing with a lid for holding a cartridge, where the lid has a cartridge sleeve into which the cartridge is inserted, and where the sleeve has two longitudinally spaced sections which exert different rotational forces on the cartridge, and where the cartridge comprises an aerosol generator. The different biases hold the cartridge securely.
Patent PT-100205-A (PT)
Inventor: ROBINSON SCOTT G
IPC: G06F9/44
Filed: 1992-03-06
Abstract: A system or method is provided for translating a first program code to a second program code and for executing the second program code while preserving instruction state-atomicity of the first code. The first program code is executable on a computer having a first architecture adapted to a first instruction set and the second program code is executable on a computer having a memory and register state and a second architecture adapted to a second instruction set that is reduced relative to the first instruction set. A first computer translates the first code instructions to corresponding second code instructions in accordance with a pattern code that defines first code instructions in terms of second code instructions. The second code instructions for each first code instruction organized in a granular instruction sequence having in order at least two groups, a first group having a first subgroup including second code read instructions and a second subgroup including modify instructions and a second group having a third subgroup including state update instructions subject to exception, including any special write instruction required to implement the first code instruction being translated, and a fourth subgroup including state update instructions free of exception.
Patent PT-103377-A (PT)
Inventor: VIDAL DE O. BAPTISTA MARCELO CURTO MARIA JOAO
IPC: A61P31/06
Filed: 2005-11-02
Abstract: The present invention relates to extracts from species of the genus  Hypericum  L., namely  H .  humifusum  L.,  H. calycinum L., H. elodes  L ., H. hircinum  subsp.  majus  (Aiton) N. Robson,  H .  glandulosum  Aiton,  H .  grandifolium  Choisy and  H .  foliosum  Aiton, obtained by extraction with an hydroxylated solvent or mixtures with water in order to obtain, after solvent evaporation, concentrated extracts active against multidrug-resistant strains of  Mycobacterium tuberculosis.  The invention also relates to a method of preparation of the above extracts as well as to pharmaceutical compositions that contain these extracts, useful in the treatment and/or prevention of persistent tuberculosis.